Drug Trial Radar · NCT04676633
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Last checked: Nov 19, 2026Latest source record: Mar 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5
Actual
Start
Mar 1, 2021
Primary completion
Jan 13, 2023
Study completion Jan 13, 2023
Sponsor
- Lead sponsor
- SirnaomicsIndustry
- Sponsor type
- Industry
- Collaborators
- Translational Drug Development
- First posted
- Dec 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of STP705 administered intratumorally in cholangiocarcinoma, hepatocellular carcinoma or liver metastasis in subjects with advanced/metastatic or surgically unresectable solid tumors who are refractory to standard therapy. Goals: 1. To determine the MTD or RP2D of STP705 when administered intratumorally into cholangiocarcinoma, hepatocellular carcinoma, or liver metastasis. 2. To establish the dose of STP705 recommended for future phase 2 studies when administered intratumorally.
Conditions
- Hepatocellular Carcinoma
- Liver Metastases
- Cholangiocarcinoma
Interventions
STP705Drug
Investigational Product
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Tolerated Dose (MTD)Time frame: 28 day cycle
- Limited Dose Toxicity (LTD)Time frame: 28 day cycle
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Honor Health
Scottsdale, Arizona
USC Norris Comprehensive Cancer Center
Los Angeles, California
Norton Cancer Institute
Louisville, Kentucky
Atlantic Health System
Morristown, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.